C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

All articles by C. Andrew Kistler, MD, PharmD

feature

IBD and Obesity: Is there a Connection?

One key factor that has developed increasing research interest is the role of a patient’s BMI, specifically those with obesity (BMI > 30 kg/m2), in the development of IBD.

C. Andrew Kistler, MD, PharmD

September 24, 2021

feature

IBD and Osteoporosis: Key Takeaways and New Data

Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.

C. Andrew Kistler, MD, PharmD

August 20, 2021

feature

Low FODMAP Diet and IBD: A Potential Option?

Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.

C. Andrew Kistler, MD, PharmD

June 11, 2021

feature

Pediatric Cancer Survivors and Diabetes: What Are the Risks?

Diabetes and metabolic syndrome represent two of the most common long-term complications in survivors of childhood cancer.

C. Andrew Kistler, MD, PharmD

May 5, 2021